The effectiveness of Paxlovid treatment in long-term care facilities in South Korea during the outbreak of the Omicron variant of SARS-CoV-2
Objectives On November 5, 2021, Pfizer Inc. announced Paxlovid (nirmatrelvir+ritonavir) as a treatment method that could reduce the risk of hospitalization or death for patients with confirmed coronavirus disease 2019 (COVID-19). Methods From February 6, 2022 to April 2, 2022, the incidence of COVID...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Korea Disease Control and Prevention Agency
2022-12-01
|
| Schriftenreihe: | Osong Public Health and Research Perspectives |
| Schlagworte: | |
| Online-Zugang: | http://ophrp.org/upload/pdf/j-phrp-2022-0262.pdf |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|